Event context and why Addus HomeCare is on investors’ radar
Addus HomeCare (ADUS) is drawing attention after recent trading, with the share price around $101.55 and mixed returns over the past year, month, and past 3 months prompting closer scrutiny of its valuation.
See our latest analysis for Addus HomeCare.
Recent trading has been choppy, with a 30-day share price return showing a 10.76% decline and a 90-day share price return showing a 9.39% decline, while the 1-year total shareholder return of 11.30% points to stronger longer term momentum.
If this kind of move has you thinking about where else capital could work, it might be a good time to scan opportunities in 35 healthcare AI stocks
With annual revenue of US$1.42b, net income of US$95.91m and recent share price weakness, the key question is whether Addus HomeCare is trading below its underlying worth or if the market is already pricing in future growth.
Most Popular Narrative: 28.9% Undervalued
With Addus HomeCare last closing at $101.55 against a narrative fair value of $142.91, the widely followed view points to a meaningful valuation gap built on detailed long term forecasts.
Recent and upcoming state-level reimbursement rate increases in major markets (Illinois and Texas) are expected to add over $35 million in annualized revenue at stable 20%+ margins, directly supporting top-line growth and net margin expansion. Consistently strong organic growth in the core Personal Care segment, driven by robust hiring, technology-enabled operations, and improving same-store service volumes, positions Addus to further capitalize on the preference for aging-in-place and rising demand for home-based care, boosting recurring revenue and operating leverage.
Curious what earnings path, revenue mix, and margin profile are baked into that higher fair value? The narrative leans on firm growth assumptions and a future P/E multiple that sits above the broader US healthcare peer group.
Result: Fair Value of $142.91 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, you still need to factor in risks such as possible reimbursement cuts and ongoing wage pressure, which could squeeze margins and unsettle the current narrative.
Find out about the key risks to this Addus HomeCare narrative.
Next Steps
With sentiment leaning cautiously optimistic, it helps to move fast, test the assumptions, and stress test the upside and downside for yourself. To understand what the market currently views as the key positives, take a closer look at the 5 key rewards.
Looking for more investment ideas?
If you stop with a single stock, you risk missing out on other opportunities that fit your style, so put the Simply Wall St Screener to work now.
- Target potential mispricings across the market by checking companies highlighted in the 49 high quality undervalued stocks.
- Prioritize resilience by focusing on businesses featured in the 73 resilient stocks with low risk scores.
- Hunt for future standouts before the crowd pays attention by using the screener containing 26 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com